Avalo Therapeutics, Inc. (AVTX)
16.12
-1.06
(-6.17%)
USD |
NASDAQ |
Sep 11, 16:00
16.11
-0.01
(-0.06%)
After-Hours: 20:00
Avalo Therapeutics Price to Book Value : 1.901 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.901 |
| September 10, 2026 | 2.026 |
| September 09, 2026 | 2.147 |
| September 08, 2026 | 2.324 |
| September 04, 2026 | 2.267 |
| September 03, 2026 | 2.240 |
| September 02, 2026 | 2.280 |
| September 01, 2026 | 2.234 |
| August 31, 2026 | 2.280 |
| August 28, 2026 | 2.310 |
| August 27, 2026 | 2.364 |
| August 26, 2026 | 2.423 |
| August 25, 2026 | 2.328 |
| August 24, 2026 | 2.272 |
| August 21, 2026 | 2.338 |
| August 20, 2026 | 2.337 |
| August 19, 2026 | 2.447 |
| August 18, 2026 | 2.324 |
| August 17, 2026 | 2.352 |
| August 14, 2026 | 2.310 |
| August 13, 2026 | 2.293 |
| August 12, 2026 | 2.305 |
| August 11, 2026 | 2.296 |
| August 10, 2026 | 2.331 |
| August 07, 2026 | 2.160 |
| Date | Value |
|---|---|
| August 06, 2026 | 2.205 |
| August 05, 2026 | 2.221 |
| August 04, 2026 | 2.185 |
| August 03, 2026 | 2.128 |
| July 31, 2026 | 2.152 |
| July 30, 2026 | 2.286 |
| July 29, 2026 | 2.241 |
| July 28, 2026 | 2.302 |
| July 27, 2026 | 2.299 |
| July 24, 2026 | 2.174 |
| July 23, 2026 | 2.094 |
| July 22, 2026 | 2.14 |
| July 21, 2026 | 2.219 |
| July 20, 2026 | 2.147 |
| July 17, 2026 | 2.284 |
| July 16, 2026 | 2.108 |
| July 15, 2026 | 2.187 |
| July 14, 2026 | 2.172 |
| July 13, 2026 | 2.230 |
| July 10, 2026 | 2.265 |
| July 09, 2026 | 2.352 |
| July 08, 2026 | 2.265 |
| July 07, 2026 | 2.270 |
| July 06, 2026 | 2.353 |
| July 02, 2026 | 2.221 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Incyte Corp. | 3.848 |
| AbbVie, Inc. | -- |
| Rezolute, Inc. | 3.478 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
Price to Book Value Related Metrics
| PS Ratio | 6572.47 |
| Price | 16.12 |
| Earnings Yield | -29.40% |
| Market Cap | 852.76M |